Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients.

AIM Thromboxane A synthase (TBXAS1) converts prostaglandin H to thromboxane A, a potent constrictor of smooth respiratory muscle. Thus, functional alterations of the TBXAS1 gene may contribute to aspirin-intolerant asthma (AIA). MATERIALS & METHODS We investigated the relationship between SNPs in the TBXAS1 gene and AIA. Asthmatics (n = 470) were categorized into AIA (20% or greater decreases in forced expiratory volume in 1 s [FEV(1)], or 15% to 19% decreases in FEV(1) with naso-ocular or cutaneous reactions) and aspirin-tolerant asthma (ATA). A total of 101 SNPs were genotyped. mRNA expression of the TBXAS1 gene by peripheral blood mononuclear cells and plasma thromboxane B2 (TXB2) concentrations were measured by reverse transcriptase (RT)-PCR and ELISA. RESULTS Logistic regression analysis showed that the rare allele frequency of rs6962291 in intron 9 was significantly lower in the AIA group (n = 115) than in the ATA group (n = 270) (p(corr) = 0.04). The linear regression analysis revealed a strong association of rs6962291 with the aspirin challenge-induced FEV(1) fall (p = 0.003). RT-PCR revealed an exon-12-deleted splice variant. We measured TBXAS1 mRNA levels in peripheral blood mononuclear cells. The mRNA levels of the full-length wild-type and splice variant were significantly higher in the TT homozygotes than in the AA homozygotes of rs6962291 (1.00 ± 0.18 vs 0.57 ± 0.03 and 1.00 ± 0.18 vs 0.21 ± 0.05, p = 0.047 and 0.001, respectively). The plasma TXB2 level was significantly lower in rs6962291 AA carriers than in rs6962291 TT (p = 0.016) carriers. CONCLUSION The rare allele of rs6962291 may play a protective role against aspirin hypersensitivity via a lower catalytic activity of the TBXAS1 gene, attributed to the increase of a nonfunctioning isoform of TBXAS1.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  T. Nakajima,et al.  Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. , 2004, Human molecular genetics.

[3]  A. Munnich,et al.  Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome) , 2008, Nature Genetics.

[4]  S. Dahlén,et al.  Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. , 1992, The American review of respiratory disease.

[5]  Francisco E. Baralle,et al.  Genomic variants in exons and introns: identifying the splicing spoilers , 2004, Nature Reviews Genetics.

[6]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[7]  D. Stevenson,et al.  Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  T. Shimoda,et al.  Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. , 2002, Chest.

[9]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[10]  B. Lipworth,et al.  Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. , 2008, The Journal of allergy and clinical immunology.

[11]  Philip S Rosenberg,et al.  PGA: power calculator for case-control genetic association analyses , 2008, BMC Genetics.

[12]  A. Ford-hutchinson,et al.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. , 1991, The American review of respiratory disease.

[13]  J. McGrath,et al.  A Systematic Review of the Prevalence of Schizophrenia , 2005, PLoS medicine.

[14]  E. Shephard,et al.  Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. , 1985, British journal of clinical pharmacology.

[15]  S. Narumiya,et al.  Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis , 1993, The Journal of experimental medicine.

[16]  J. Oates,et al.  Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. , 1994, American journal of respiratory and critical care medicine.

[17]  V. Ullrich,et al.  Immunohistochemical localization of thromboxane synthase in human tissues. , 1990, Eicosanoids.

[18]  V. Ullrich,et al.  Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. , 1985, The Journal of biological chemistry.

[19]  S. Farooque,et al.  Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  J. Oates,et al.  Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. , 1996, American journal of respiratory and critical care medicine.

[21]  T. Lee,et al.  Urinary leukotriene E4 in bronchial asthma. , 1992, The European respiratory journal.

[22]  S. Bandoh,et al.  Characterization of the human gene (TBXAS1) encoding thromboxane synthase. , 1994, European journal of biochemistry.

[23]  H. Tai,et al.  Immunoaffinity purification and characterization of thromboxane synthase from porcine lung. , 1986, The Journal of biological chemistry.

[24]  C. Page,et al.  Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma. , 1993, The Journal of allergy and clinical immunology.

[25]  H. Mita,et al.  Urinary leukotriene E4 and 11‐dehydrothromboxane B2 in patients with aspirin‐sensitive asthma , 1997, Allergy.

[26]  R. Meagher,et al.  Multiplexed, high-throughput genotyping by single-base extension and end-labeled free-solution electrophoresis. , 2002, Analytical chemistry.

[27]  D. Stevenson,et al.  Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. , 2003, The Journal of allergy and clinical immunology.

[28]  H. Shin,et al.  Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics , 2005, Pharmacogenetics and genomics.

[29]  M. Fujimura,et al.  Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. , 1986, Thorax.

[30]  P. Hedrick,et al.  Gametic disequilibrium measures: proceed with caution. , 1987, Genetics.

[31]  H. Arita,et al.  Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells. , 1990, Biochemical pharmacology.

[32]  D. Stevenson,et al.  Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. , 1992, The Journal of allergy and clinical immunology.

[33]  M. Samter,et al.  Concerning the nature of intolerance to aspirin. , 1967, The Journal of allergy.

[34]  H. Shin,et al.  Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics , 2009, Allergy, asthma & immunology research.

[35]  R. Tazawa,et al.  Alternate splicing of human thromboxane synthase mRNA. , 1994, Archives of Biochemistry and Biophysics.

[36]  F. Sun,et al.  Thromboxane A2 biosynthesis in human lung fibroblasts WI-38. , 1978, Biochemical and biophysical research communications.

[37]  D. Nyholt.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[38]  C. Page,et al.  Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. , 2004, Blood.

[39]  J. Holloway,et al.  Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid‐intolerant asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[40]  H. Tai,et al.  Thromboxanes: synthase and receptors. , 1998, Journal of biomedical science.

[41]  K. Silina,et al.  Alterations of pre‐mRNA splicing in cancer , 2005, Genes, chromosomes & cancer.

[42]  Julian C. Knight,et al.  Regulatory polymorphisms underlying complex disease traits , 2005, Journal of Molecular Medicine.

[43]  H. Shin,et al.  Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase , 2004, Human Genetics.

[44]  J. Salmon,et al.  The source of thromboxane and prostaglandins in experimental inflammation , 1983, British journal of pharmacology.

[45]  V. Ullrich,et al.  Immunoquantitation of thromboxane synthase in human tissues. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[46]  S. Schwartz,et al.  Mapping of the human thromboxane synthase gene (TBXAS1) to chromosome 7q34-q35 by two-color fluorescence in situ hybridization. , 1993, Genomics.

[47]  I. Chung,et al.  Association of angiotensin I‐converting enzyme gene polymorphisms with aspirin intolerance in asthmatics , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.